top of page

About Us

Orsight Pharma is at the forefront of developing an innovative drug for Neovascular Age-Related Macular Degeneration (nAMD or wet AMD), an advanced form of eye disease that is the leading cause of severe vision loss and blindness in developed countries. At Orsight Pharma, we are dedicated to preventing blindness and improving the anatomical and visual outcomes, as well as the quality of life for nAMD patients.

bottom of page